Plain-English translation of NCT07575269 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This clinical trial is testing the FARAFLEX Mapping and Pulsed Field Ablation System, a newer device designed to treat atrial fibrillation—a condition where your heart's upper chambers beat irregularly. The device uses special energy pulses to help restore your heart's normal rhythm. Researchers want to learn if this treatment is safe and effective for people whose symptoms haven't improved with medications alone.
Many people with atrial fibrillation don't respond well enough to medications, and their irregular heartbeat causes uncomfortable symptoms and health risks. This trial exists to see if this new treatment method offers a better option for these patients.
You likely qualify if…
You likely don't qualify if…
If you qualify for this trial, you will undergo a catheter-based ablation procedure using the FARAFLEX system. During the procedure, doctors will insert a thin tube (catheter) through a vein to map your heart's electrical signals and then deliver pulsed energy to the areas causing your irregular rhythm. You will be required to return for follow-up visits and assessments to monitor your recovery and how well the treatment is working.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States